Model-generated Probability of Death from Endocarditis by Age 60, Stratified by Age at Initiation of Injection Opioid Use and Injection Behavior Profile
. | Probability of Endocarditis Death by Age 60 Years, % (rangea) . | |||||
---|---|---|---|---|---|---|
. | Began Use at Age 20 . | Began Use at Age 30 . | Began Use at Age 40 . | |||
. | Female . | Male . | Female . | Male . | Female . | Male . |
High frequency, higher infection risk | 54.4 (38.2–83.6) | 53.8 (37.7–83.1) | 52.0 (36.3–83.4) | 51.4 (35.9–82.8) | 45.2 (30.7–81.3) | 44.5 (30.2–80.5) |
High frequency, lower infection risk | 3.8 (0–13.6) | 3.8 (13.4) | 3.1 (0–11.7) | 3.1 (0–11.6) | 2.2 (0–8.8) | 2.2 (0–8.7) |
Low frequency, higher infection risk | 45.8 (31.1–90.7) | 44.9 (30.4–89.5) | 37.4 (23.3–84.0) | 36.8 (22.8–82.9) | 26.0 (13.7–68.8) | 25.6 (13.4–67.7) |
Low frequency, lower infection risk | 2.5 (0–10.7) | 2.5 (0–10.4) | 1.9 (0–7.9) | 1.8 (0–7.8) | 1.2 (0–5.1) | 1.2 (0–5.1) |
. | Probability of Endocarditis Death by Age 60 Years, % (rangea) . | |||||
---|---|---|---|---|---|---|
. | Began Use at Age 20 . | Began Use at Age 30 . | Began Use at Age 40 . | |||
. | Female . | Male . | Female . | Male . | Female . | Male . |
High frequency, higher infection risk | 54.4 (38.2–83.6) | 53.8 (37.7–83.1) | 52.0 (36.3–83.4) | 51.4 (35.9–82.8) | 45.2 (30.7–81.3) | 44.5 (30.2–80.5) |
High frequency, lower infection risk | 3.8 (0–13.6) | 3.8 (13.4) | 3.1 (0–11.7) | 3.1 (0–11.6) | 2.2 (0–8.8) | 2.2 (0–8.7) |
Low frequency, higher infection risk | 45.8 (31.1–90.7) | 44.9 (30.4–89.5) | 37.4 (23.3–84.0) | 36.8 (22.8–82.9) | 26.0 (13.7–68.8) | 25.6 (13.4–67.7) |
Low frequency, lower infection risk | 2.5 (0–10.7) | 2.5 (0–10.4) | 1.9 (0–7.9) | 1.8 (0–7.8) | 1.2 (0–5.1) | 1.2 (0–5.1) |
High infection risk was defined as persons who do not clean their skin and reuse injection equipment; low infection risk was defined as persons who clean their skin and do not reuse injection equipment.
aRanges were determined by probabilistic sensitivity analysis.
Model-generated Probability of Death from Endocarditis by Age 60, Stratified by Age at Initiation of Injection Opioid Use and Injection Behavior Profile
. | Probability of Endocarditis Death by Age 60 Years, % (rangea) . | |||||
---|---|---|---|---|---|---|
. | Began Use at Age 20 . | Began Use at Age 30 . | Began Use at Age 40 . | |||
. | Female . | Male . | Female . | Male . | Female . | Male . |
High frequency, higher infection risk | 54.4 (38.2–83.6) | 53.8 (37.7–83.1) | 52.0 (36.3–83.4) | 51.4 (35.9–82.8) | 45.2 (30.7–81.3) | 44.5 (30.2–80.5) |
High frequency, lower infection risk | 3.8 (0–13.6) | 3.8 (13.4) | 3.1 (0–11.7) | 3.1 (0–11.6) | 2.2 (0–8.8) | 2.2 (0–8.7) |
Low frequency, higher infection risk | 45.8 (31.1–90.7) | 44.9 (30.4–89.5) | 37.4 (23.3–84.0) | 36.8 (22.8–82.9) | 26.0 (13.7–68.8) | 25.6 (13.4–67.7) |
Low frequency, lower infection risk | 2.5 (0–10.7) | 2.5 (0–10.4) | 1.9 (0–7.9) | 1.8 (0–7.8) | 1.2 (0–5.1) | 1.2 (0–5.1) |
. | Probability of Endocarditis Death by Age 60 Years, % (rangea) . | |||||
---|---|---|---|---|---|---|
. | Began Use at Age 20 . | Began Use at Age 30 . | Began Use at Age 40 . | |||
. | Female . | Male . | Female . | Male . | Female . | Male . |
High frequency, higher infection risk | 54.4 (38.2–83.6) | 53.8 (37.7–83.1) | 52.0 (36.3–83.4) | 51.4 (35.9–82.8) | 45.2 (30.7–81.3) | 44.5 (30.2–80.5) |
High frequency, lower infection risk | 3.8 (0–13.6) | 3.8 (13.4) | 3.1 (0–11.7) | 3.1 (0–11.6) | 2.2 (0–8.8) | 2.2 (0–8.7) |
Low frequency, higher infection risk | 45.8 (31.1–90.7) | 44.9 (30.4–89.5) | 37.4 (23.3–84.0) | 36.8 (22.8–82.9) | 26.0 (13.7–68.8) | 25.6 (13.4–67.7) |
Low frequency, lower infection risk | 2.5 (0–10.7) | 2.5 (0–10.4) | 1.9 (0–7.9) | 1.8 (0–7.8) | 1.2 (0–5.1) | 1.2 (0–5.1) |
High infection risk was defined as persons who do not clean their skin and reuse injection equipment; low infection risk was defined as persons who clean their skin and do not reuse injection equipment.
aRanges were determined by probabilistic sensitivity analysis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.